[Biochemical mechanisms of regulation of hydrochloric acid secretion in the stomach]. - Suppr | 超能文献

[Biochemical mechanisms of regulation of hydrochloric acid secretion in the stomach].

作者信息

Salganik R I, Bersimbaev R I, Argutinskaia S V

出版信息

Dokl Akad Nauk SSSR. 1972 Sep 1;206(1):236-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Biochemical mechanisms of regulation of hydrochloric acid secretion in the stomach].

Dokl Akad Nauk SSSR. 1972 Sep 1;206(1):236-9.

2

The stimulating action of gastrin pentapeptide, histamine and cyclic adenosine 3',5'-monophosphate on carbonic anhydrase in rat stomach.胃泌素五肽、组胺和环磷酸腺苷对大鼠胃碳酸酐酶的刺激作用。

Experientia. 1972 Oct 15;28(10):1190-1. doi: 10.1007/BF01946162.

3

[The effect of pentagastrin, histamine and cyclic 3',5'-AMP on rat gastric mucosal carbonic anhydrase activity].[五肽胃泌素、组胺和环磷酸腺苷对大鼠胃黏膜碳酸酐酶活性的影响]

Biokhimiia. 1973 Jan-Feb;38(1):174-7.

4

[Role of a genetic factor in the stimulating action of gastrin pentapeptide on gastric juice secretion in the stomach].

Vopr Med Khim. 1971 Sep-Oct;17(5):516-9.

5

[Effect of pentagastrin and histamine on adenyl cyclase activity in the rat stomach].[五肽胃泌素和组胺对大鼠胃腺苷酸环化酶活性的影响]

Biokhimiia. 1972 Jul-Aug;37(4):792-6.

6

[Adenylate cyclase and gastric acid secretion].[腺苷酸环化酶与胃酸分泌]

Med Klin. 1976 Jun 4;71(23):980-6.

7

Gastric histamine receptors and cyclic AMP.胃组胺受体与环磷酸腺苷

Indian J Physiol Pharmacol. 1979 Apr-Jun;23(2):57-67.

8

Role of cyclic AMP system in humorally stimulated gastric acid secretion.环磷酸腺苷系统在体液刺激胃酸分泌中的作用。

Surg Forum. 1974;25(0):343-5.

9

Studies on the mode of action of cyclic 3'5'-AMP and prostaglndin E 2 on rat gastric acid secretion and mucosal blood flow.关于环磷酸腺苷（cAMP）和前列腺素E2对大鼠胃酸分泌及黏膜血流作用方式的研究。

Br J Pharmacol. 1972 Nov;46(3):546P-547P.

10

Mucosal cyclic AMP and secretion in the dog stomach.犬胃黏膜中的环磷酸腺苷与分泌

Am J Physiol. 1973 Oct;225(4):893-6. doi: 10.1152/ajplegacy.1973.225.4.893.

引用本文的文献

1

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).干扰素与多发性硬化症：肌肉内注射干扰素 β-1a（倍泰龙）25 年的临床与真实世界经验教训。

CNS Drugs. 2021 Jul;35(7):743-767. doi: 10.1007/s40263-021-00822-z. Epub 2021 Jul 6.

2

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison.基于匹配调整间接比较的奥扎尼莫德与富马酸二甲酯治疗复发缓解型多发性硬化症的疗效和安全性比较

CNS Drugs. 2021 Jul;35(7):795-804. doi: 10.1007/s40263-021-00805-0. Epub 2021 Apr 13.

3

Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis.真实世界证据：多发性硬化症患者的社会经济复发成本。

Pharmacoeconomics. 2020 Aug;38(8):883-892. doi: 10.1007/s40273-020-00917-3.

4

Multiple sclerosis.多发性硬化症。

Nat Rev Dis Primers. 2018 Nov 8;4(1):43. doi: 10.1038/s41572-018-0041-4.